Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
bluebird bio revenue
bluebird bio's revenue is $3.7 million.
What is bluebird bio's revenue?
- Bluebird bio's revenue growth from 2012 to 2021 is 977.06%.
- Bluebird bio has 518 employees, and the revenue per employee ratio is $7,069.
- Bluebird bio's peak quarterly revenue was $12.4M in 2023(q3).
- Bluebird bio peak revenue was $54.6M in 2018.
- Bluebird bio annual revenue for 2018 was 54.6M, 54.06% growth from 2017.
- Bluebird bio annual revenue for 2021 was 3.7M, -93.29% growth from 2018.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
bluebird bio historical revenue
Bluebird bio's peak revenue was $54.6M in 2018. The peak quarterly revenue was $12.4M in 2023(q3).
Bluebird bio's revenue increased from $340.0k in 2012 to $3.7M currently. That's a 977.06% change in annual revenue.
bluebird bio annual revenue
bluebird bio annual revenue over time
| Fiscal year / year | bluebird bio revenue |
|---|---|
| 2012 | $340,000 |
| 2013 | $20.2M |
| 2014 | $25.4M |
| 2015 | $14.1M |
| 2016 | $6.2M |
| 2017 | $35.4M |
| 2018 | $54.6M |
| 2021 | $3.7M |
How accurately did bluebird bio's revenue projections match actual performance?
bluebird bio annual growth
Bluebird bio saw the greatest revenue growth in 2013, when revenue increased by 5,835.59%.
Bluebird bio had the lowest revenue growth in 2021, when revenue changed by -93.29%.
bluebird bio annual growth rate over time
| Year | bluebird bio growth |
|---|---|
| 2013 | 5836%↑ |
| 2014 | 26%↑ |
| 2015 | -45%↓ |
| 2016 | -56%↓ |
| 2017 | 476%↑ |
| 2018 | 54%↑ |
| 2021 | -93%↓ |
bluebird bio jobs nearby
Do you work at bluebird bio?
Is bluebird bio transparent about its revenue structure?
bluebird bio financial information
| CEO | Nick Leschly |
| Company Type | Public |
| Employees Number | 518 |
| Date Founded | 1992 |
| Headquarters | Cambridge, Massachusetts |
| Number of Locations | 5 |
| Revenue | $3.7M |
| Net Income | -$266,578,000 |
| Gross Proft | ($35.2M) (2021) |
| PE Ratio | -8.20 |
| Tax Rate | -0.0% |
| Market Capitalization | $6.7B |
| Total Assets | $554,902,000 |
| Ticker | BLUE |
bluebird bio jobs you might like
bluebird bio financing
Bluebird bio received early financing of $8.5M on 2004-06-17.
| Series | Round size | Date |
|---|---|---|
| Series A | $8.5M | 06/2004 |
| Series Unknown | $12M | 10/2004 |
| Series B | $35M | 03/2010 |
| Grant | $4.2M | 03/2011 |
| Series C | $30M | 04/2011 |
| Series D | $60M | 07/2012 |
| Series Unknown | $9.3M | 10/2012 |
| Post Ipo Equity | $250M | 12/2016 |
| Post Ipo Equity | $75M | 09/2021 |
bluebird bio investors
| Investors | Security type |
|---|---|
| NAZEM & CO LP | Series A |
| ABN AMRO Bank | Series A |
| Techno Venture Management | Series Unknown |
| ABN AMRO Bank | Series Unknown |
| Easton Capital Investment Group | Series Unknown |
| Forbion Capital Partners | Series B |
| TVM Capital Life Science | Series B |
| Third Rock Ventures | Series B |
| Sanofi Ventures | Series B |
| Easton Capital Investment Group | Series B |
| Forbion Capital Partners | Series C |
| TVM Capital Life Science | Series C |
| ARCH Venture Partners | Series C |
| Third Rock Ventures | Series C |
| Easton Capital Investment Group | Series C |
| Deerfield Partners | Series D |
| Forbion Capital Partners | Series D |
| TVM Capital Life Science | Series D |
| Third Rock Ventures | Series D |
| ARCH Venture Partners | Series D |
| Ramius LLC | Series D |
| RA Capital Management | Series D |
| California Institute for Regenerative Medicine | Series Unknown |
bluebird bio competitors
Bluebird bio's top competitor, Sarepta Therapeutics, earned an annual revenue of $1.9B.
Bluebird bio's smallest competitor is Homology Medicines with revenue of $-6.7M last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Acceleron Pharma | - | $92.5M | 312 | - |
| Sarepta Therapeutics | - | $1.9B | 840 | - |
| Homology Medicines | - | ($6.7M) | 124 | - |
| Poseida Therapeutics | - | $64.7M | 200 | - |
| Eiger BioPharmaceuticals | - | $15.8M | 28 | - |
| Genprex | - | $45.0M | 7 | - |
| Abeona Therapeutics | - | $1.4M | 83 | - |
| Cabaletta Bio | - | $1.6M | 20 | - |
| AVROBIO | - | $1.2M | 49 | - |
| PTC Therapeutics | - | $806.8M | 517 | - |
Search for jobs
Related company revenues
Working at related companies
Related company jobs
bluebird bio highest paying jobs
Zippia gives an in-depth look into the details of bluebird bio, including salaries, political affiliations, employee data, and more, in order to inform job seekers about bluebird bio. The employee data is based on information from people who have self-reported their past or current employments at bluebird bio. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by bluebird bio. The data presented on this page does not represent the view of bluebird bio and its employees or that of Zippia.
bluebird bio may also be known as or be related to Bluebird Bio, Bluebird Bio, Inc., bluebird bio, bluebird bio Inc, bluebird bio Inc. and bluebird bio, Inc.